missing translation for 'onlineSavingsMsg'
Learn More

Levetiracetam, Tocris Bioscience™

Catalog Number 18742594
Click to view available options
Quantity:
10 mg
50 mg
This item is not returnable. View return policy
102767-28-2
C8H14N2O2
170.21
MFCD03265610
HPHUVLMMVZITSG-ZCFIWIBFSA-N
levetiracetam, keppra, s-2-2-oxopyrrolidin-1-yl butanamide, keppra xr, 2s-2-2-oxopyrrolidin-1-yl butanamide, levetiracetamum, ucb-l 059, ucb l059, levetiractam, levroxa
5284583
CHEBI:6437
(2R)-2-(2-oxopyrrolidin-1-yl)butanamide
CC[C@@H](N1CCCC1=O)C(N)=O
This item is not returnable. View return policy
102767-28-2
C8H14N2O2
170.21
MFCD03265610
HPHUVLMMVZITSG-ZCFIWIBFSA-N
levetiracetam, keppra, s-2-2-oxopyrrolidin-1-yl butanamide, keppra xr, 2s-2-2-oxopyrrolidin-1-yl butanamide, levetiracetamum, ucb-l 059, ucb l059, levetiractam, levroxa
5284583
CHEBI:6437
(2R)-2-(2-oxopyrrolidin-1-yl)butanamide
CC[C@@H](N1CCCC1=O)C(N)=O

Antiepileptic; binds SV2A

Levetiracetam is an antiepileptic that displays distinctive properties from conventional antiepileptic drugs. Displays potent seizure protection in animal models of chronic epilepsy but lacks activity in acute seizure models. Binds synaptic vesicle protein 2A (SV2A) and inhibits Na+-dependent Cl-/HCO3- exchange. In a mouse model of Alzheimer's disease, Levetiracetam rescues levels of presynaptic vesicle fusion and neurotransmitter release, reduces Aβ42 and APP levels and decreases deposits of amyloid plaque; in vitro Levetiracetam inhibits Aβ-induced glutamate from astrocytes.
Quantity 50 mg
Formula Weight 170.21
Percent Purity >99%
Chemical Name or Material Levetiracetam
missing translation for 'provideContentCorrection'

missing translation for 'productTitle'